Table S4.
Antigen | Antibody | Source | Dilution | |
IHC | IF | |||
COX-1 | sc-1752 | Santa Cruz Biotechnology | 1:200 | |
COX-1 | 160108 | Cayman | 1:3,200 | |
COX-2 | 160112 | Cayman | 1:50 | |
mPGES-1 | (31) | In house | 1:5,000 | 1:4,000 |
L-PGDS | 160003 | Cayman | 1:800 | |
H-PGDS | 160013 | Cayman | 1:800 | |
15-PGDH | 10007950 | Cayman | 1:3,200 | |
GD2 | MAB2052 | Millipore | 1:15000 | |
CD31 | M0823 | DAKO | 1:80 | |
CD68 | M0718 | DAKO | 1:16000 | |
CD163 | M0794 | DAKO | 1:100 | 1:80 |
CD206 | MCA2155 | AbD Serotec | 1:200 | |
HLA-DR (MHCII) | M0746 | DAKO | 1:3,000 | |
CD11b | 301302 | BioLegend | 1:200 | |
CD11c | 301615 | BioLegend | 1:5,000 | |
CD3 | 347340 | BD Biosciences | 1:640 | |
CD20 | M0755 | DAKO | 1:200 | |
Vimentin | M0725 | DAKO | 1:10000 | |
αSMA | M0851 | DAKO | 1:200 | |
FAP | BMS168 | eBioscience | 1:400 | |
FSP-1 | AMAb90599 | Atlas Antibodies | 1:2,500 | |
PDGFRα | sc-21789 | Santa Cruz Biotechnology | 1:250 | |
PDGFRβ | 3175 | Cell Signaling | 1:100 |